2-232334711-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4BP6_Very_StrongBP7BS1BS2

The NM_152383.5(DIS3L2):​c.2370C>T​(p.Gly790Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00414 in 1,608,166 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0023 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0043 ( 8 hom. )

Consequence

DIS3L2
NM_152383.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.00500

Publications

2 publications found
Variant links:
Genes affected
DIS3L2 (HGNC:28648): (DIS3 like 3'-5' exoribonuclease 2) The protein encoded by this gene is similar in sequence to 3'/5' exonucleolytic subunits of the RNA exosome. The exosome is a large multimeric ribonucleotide complex responsible for degrading various RNA substrates. Several transcript variants, some protein-coding and some not, have been found for this gene. [provided by RefSeq, Mar 2012]
DIS3L2 Gene-Disease associations (from GenCC):
  • Perlman syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.287).
BP6
Variant 2-232334711-C-T is Benign according to our data. Variant chr2-232334711-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 241975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.005 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00232 (354/152348) while in subpopulation NFE AF = 0.00388 (264/68030). AF 95% confidence interval is 0.0035. There are 0 homozygotes in GnomAd4. There are 170 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIS3L2NM_152383.5 linkc.2370C>T p.Gly790Gly synonymous_variant Exon 19 of 21 ENST00000325385.12 NP_689596.4 Q8IYB7-1
DIS3L2NR_046476.2 linkn.2443C>T non_coding_transcript_exon_variant Exon 19 of 21
DIS3L2NR_046477.2 linkn.2422C>T non_coding_transcript_exon_variant Exon 18 of 19
DIS3L2NM_001257281.2 linkc.1582-8634C>T intron_variant Intron 13 of 13 NP_001244210.1 Q8IYB7-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIS3L2ENST00000325385.12 linkc.2370C>T p.Gly790Gly synonymous_variant Exon 19 of 21 5 NM_152383.5 ENSP00000315569.7 Q8IYB7-1

Frequencies

GnomAD3 genomes
AF:
0.00233
AC:
354
AN:
152230
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000796
Gnomad AMI
AF:
0.00549
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00388
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00280
AC:
669
AN:
238674
AF XY:
0.00284
show subpopulations
Gnomad AFR exome
AF:
0.000891
Gnomad AMR exome
AF:
0.00139
Gnomad ASJ exome
AF:
0.000203
Gnomad EAS exome
AF:
0.000346
Gnomad FIN exome
AF:
0.00250
Gnomad NFE exome
AF:
0.00469
Gnomad OTH exome
AF:
0.00397
GnomAD4 exome
AF:
0.00433
AC:
6301
AN:
1455818
Hom.:
8
Cov.:
33
AF XY:
0.00422
AC XY:
3052
AN XY:
723868
show subpopulations
African (AFR)
AF:
0.000871
AC:
29
AN:
33308
American (AMR)
AF:
0.00174
AC:
77
AN:
44276
Ashkenazi Jewish (ASJ)
AF:
0.000230
AC:
6
AN:
26036
East Asian (EAS)
AF:
0.000102
AC:
4
AN:
39340
South Asian (SAS)
AF:
0.00105
AC:
90
AN:
85378
European-Finnish (FIN)
AF:
0.00256
AC:
134
AN:
52292
Middle Eastern (MID)
AF:
0.000367
AC:
2
AN:
5456
European-Non Finnish (NFE)
AF:
0.00520
AC:
5770
AN:
1109600
Other (OTH)
AF:
0.00314
AC:
189
AN:
60132
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.422
Heterozygous variant carriers
0
342
684
1025
1367
1709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00232
AC:
354
AN:
152348
Hom.:
0
Cov.:
33
AF XY:
0.00228
AC XY:
170
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000794
AC:
33
AN:
41584
American (AMR)
AF:
0.00137
AC:
21
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5174
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4830
European-Finnish (FIN)
AF:
0.00188
AC:
20
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00388
AC:
264
AN:
68030
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00345
Hom.:
1
Bravo
AF:
0.00254

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Perlman syndrome Benign:3
Jan 07, 2021
Sema4, Sema4
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not provided Benign:2
Apr 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DIS3L2: BP4, BP7 -

not specified Benign:1
Aug 19, 2021
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.27
CADD
Benign
12
DANN
Benign
0.94
PhyloP100
0.0050
PromoterAI
-0.020
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199541622; hg19: chr2-233199421; API